JNCE Quarterly Accounts Receivable
N/A
31 December 2022
Summary:
JNCE quarterly accounts receivable is not available.JNCE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JNCE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
JNCE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Jounce Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $24.98 M |
FAQ
- What is the all time high quarterly accounts receivable for Jounce Therapeutics?
What is the all time high quarterly accounts receivable for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly accounts receivable is $24.98 M